TW201907948A - 組成物 - Google Patents

組成物 Download PDF

Info

Publication number
TW201907948A
TW201907948A TW107108820A TW107108820A TW201907948A TW 201907948 A TW201907948 A TW 201907948A TW 107108820 A TW107108820 A TW 107108820A TW 107108820 A TW107108820 A TW 107108820A TW 201907948 A TW201907948 A TW 201907948A
Authority
TW
Taiwan
Prior art keywords
composition
coenzyme
powder
disease
brain
Prior art date
Application number
TW107108820A
Other languages
English (en)
Chinese (zh)
Inventor
井徳行
松岡忠司
Original Assignee
日商酵素股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商酵素股份有限公司 filed Critical 日商酵素股份有限公司
Publication of TW201907948A publication Critical patent/TW201907948A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW107108820A 2017-07-18 2018-03-15 組成物 TW201907948A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-139099 2017-07-18
JP2017139099A JP6253837B1 (ja) 2017-07-18 2017-07-18 組成物

Publications (1)

Publication Number Publication Date
TW201907948A true TW201907948A (zh) 2019-03-01

Family

ID=60860165

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107108820A TW201907948A (zh) 2017-07-18 2018-03-15 組成物

Country Status (4)

Country Link
JP (1) JP6253837B1 (ja)
CN (1) CN109562131A (ja)
TW (1) TW201907948A (ja)
WO (1) WO2019016988A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201929877A (zh) * 2017-12-29 2019-08-01 大江生醫股份有限公司 地龍蛋白用於製造保護腦神經細胞醫藥組成物之用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900012617A (ko) * 1987-10-28 1990-09-01 요오이찌 이시이 혈전증 치료제 및 그 제조방법
JP2732109B2 (ja) * 1989-02-10 1998-03-25 正樹 今川 痴呆治療剤
JP2005328803A (ja) * 2004-05-21 2005-12-02 Towa Kagaku Kk 活力促進・老化防止食品及びその製造方法
US10155012B2 (en) * 2014-01-20 2018-12-18 Well Stone Co. Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
JP2017025019A (ja) * 2015-07-21 2017-02-02 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物

Also Published As

Publication number Publication date
JP2019019084A (ja) 2019-02-07
JP6253837B1 (ja) 2017-12-27
WO2019016988A1 (ja) 2019-01-24
CN109562131A (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
US8021659B2 (en) Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
JPH11500725A (ja) ピペリンのバイオアベイラビリティ増強剤としての使用
TW201943417A (zh) 認知功能改善用食品組成物、認知功能改善劑、及其製造方法
JP2019019142A (ja) Ｖｃａｍ−１発現抑制剤
JP2016199491A (ja) 気分状態改善剤
KR101522123B1 (ko) 인지 기능 개선을 위한 병용제
JP2019054791A (ja) 疲労改善用組成物
TW201907948A (zh) 組成物
JP5759047B1 (ja) ウコン中の有用成分を含有する低水分系組成物
JP5572775B1 (ja) ウコン中の有用成分を含有する低水分系組成物
JP5543656B1 (ja) ウコン中の有用成分を含有する組成物
KR102348044B1 (ko) 번아웃증후군의 예방, 개선 또는 치료용 조성물
JPWO2014010658A1 (ja) ヒハツ配合製剤
KR20060107825A (ko) 간 기능 보호 작용 조성물
US20070009620A1 (en) Cholesterol regulating agent
JP2008067637A (ja) 健康補助食品
JP3479986B2 (ja) アルコール性肝障害予防用組成物
US20150174218A1 (en) ANGIOGENIN COMPLEXES (ANGex) WITH ANABOLIC HORMONES FOR IMPROVING BONE HEALTH
US11357810B2 (en) Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods
WO2022013581A1 (en) Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function
KR20170012169A (ko) 경구용 복합제제
WO2009093353A1 (ja) 医薬組成物
KR101899086B1 (ko) 간손상 예방, 개선 또는 치료용 조성물
KR20170026241A (ko) 경구용 복합제제
JP4902349B2 (ja) 筋ジストロフィー進行抑制組成物